Marc Lallemant

3.8k total citations
123 papers, 2.4k citations indexed

About

Marc Lallemant is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Marc Lallemant has authored 123 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Infectious Diseases, 46 papers in Virology and 31 papers in Epidemiology. Recurrent topics in Marc Lallemant's work include HIV/AIDS Research and Interventions (82 papers), HIV/AIDS drug development and treatment (50 papers) and HIV Research and Treatment (46 papers). Marc Lallemant is often cited by papers focused on HIV/AIDS Research and Interventions (82 papers), HIV/AIDS drug development and treatment (50 papers) and HIV Research and Treatment (46 papers). Marc Lallemant collaborates with scholars based in France, Thailand and United States. Marc Lallemant's co-authors include Gonzague Jourdain, Sophie Le Cœur, Nicole Ngo‐Giang‐Huong, Suporn Koetsawang, Tim R. Cressey, Kenneth McIntosh, Pranee Leechanachai, Vallop Thaineua, Max Essex and Jean Yves Mary and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Marc Lallemant

117 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Lallemant France 25 2.0k 1.1k 760 404 393 123 2.4k
Willy Were Uganda 24 2.1k 1.1× 734 0.6× 1.2k 1.5× 354 0.9× 479 1.2× 31 2.6k
Isaac Zulu Zambia 26 2.0k 1.0× 728 0.6× 876 1.2× 402 1.0× 750 1.9× 51 2.7k
Patrick Jean‐Philippe United States 22 2.3k 1.1× 1.2k 1.1× 1.1k 1.4× 544 1.3× 295 0.8× 61 2.9k
Robert Downing Uganda 24 1.5k 0.7× 588 0.5× 729 1.0× 336 0.8× 242 0.6× 44 2.1k
Dhayendre Moodley South Africa 28 1.7k 0.8× 545 0.5× 813 1.1× 336 0.8× 811 2.1× 117 2.5k
Stewart E. Reid Zambia 21 1.7k 0.9× 531 0.5× 1.1k 1.4× 302 0.7× 595 1.5× 54 2.4k
Joseph Makhema United States 28 1.9k 0.9× 808 0.7× 818 1.1× 564 1.4× 342 0.9× 147 2.7k
Shaffiq Essajee United States 24 1.3k 0.6× 547 0.5× 493 0.6× 216 0.5× 424 1.1× 62 1.6k
Nagalingeswaran Kumarasamy India 25 1.3k 0.7× 720 0.6× 617 0.8× 287 0.7× 181 0.5× 97 1.8k
Mauro Schechter Brazil 28 3.4k 1.7× 1.6k 1.4× 1.7k 2.3× 538 1.3× 508 1.3× 62 3.9k

Countries citing papers authored by Marc Lallemant

Since Specialization
Citations

This map shows the geographic impact of Marc Lallemant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Lallemant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Lallemant more than expected).

Fields of papers citing papers by Marc Lallemant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Lallemant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Lallemant. The network helps show where Marc Lallemant may publish in the future.

Co-authorship network of co-authors of Marc Lallemant

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Lallemant. A scholar is included among the top collaborators of Marc Lallemant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Lallemant. Marc Lallemant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cressey, Tim R., Nicolas Salvadori, Helena Rabie, et al.. (2025). Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support Multidosing: PETITE-Dolutegravir Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(2). 195–201. 2 indexed citations
2.
3.
4.
Bamford, Alasdair, Alfredo Tagarro, Tim R. Cressey, et al.. (2024). Optimising Paediatric HIV Treatment: Recent Developments and Future Directions. Pediatric Drugs. 26(6). 631–648. 3 indexed citations
5.
Barbieri, Elisa, Chiara Minotti, Carlo Giaquinto, et al.. (2023). Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project. Frontiers in Pharmacology. 14. 1200848–1200848. 4 indexed citations
6.
7.
8.
McIlleron, Helen, David M. Burger, Diana M. Gibb, et al.. (2021). Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medications. British Journal of Clinical Pharmacology. 88(2). 403–415. 2 indexed citations
9.
Rabie, Helena, Janice Lee, Lee Fairlie, et al.. (2020). Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir. Antimicrobial Agents and Chemotherapy. 64(5). 4 indexed citations
10.
Nöstlinger, Christiana, Janice Lee, Olawale Salami, et al.. (2019). Understanding acceptance of and adherence to a new formulation of paediatric antiretroviral treatment in the form of pellets (LPV/r)—A realist evaluation. PLoS ONE. 14(8). e0220408–e0220408. 8 indexed citations
11.
Cressey, Tim R., Naïm Bouazza, Linda Aurpibul, et al.. (2015). Efavirenz Concentrations and Probability of HIV Replication in Children. The Pediatric Infectious Disease Journal. 34(11). 1214–1217. 6 indexed citations
12.
Sripan, Patumrat, Sophie Le Cœur, Billy Amzal, et al.. (2015). Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS ONE. 10(6). e0130917–e0130917. 1 indexed citations
13.
Lallemant, Marc, Billy Amzal, Saı̈k Urien, et al.. (2015). Antiretroviral intensification to prevent intrapartum HIV transmission in late comers. Journal of the International AIDS Society. 18. 20–21. 3 indexed citations
14.
Cressey, Tim R., Saı̈k Urien, Déborah Hirt, et al.. (2011). Influence of Body Weight on Achieving Indinavir Concentrations Within Its Therapeutic Window in HIV-Infected Thai Patients Receiving Indinavir Boosted With Ritonavir. Therapeutic Drug Monitoring. 33(1). 25–31. 4 indexed citations
15.
Briand, Nelly, Sophie Le Cœur, Gonzague Jourdain, et al.. (2010). Hematological Safety of Perinatal Exposure to Zidovudine in Uninfected Infants Born to HIV Type 1-Infected Women in Thailand. AIDS Research and Human Retroviruses. 26(10). 1163–1166. 4 indexed citations
16.
Ngo‐Giang‐Huong, Nicole, Gonzague Jourdain, Wasna Sirirungsi, et al.. (2010). Human immunodeficiency virus–hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand. International Journal of Infectious Diseases. 14(7). e602–e607. 24 indexed citations
17.
Jourdain, Gonzague, Jean–Yves Mary, Sophie Le Cœur, et al.. (2007). Risk Factors for In Utero or Intrapartum Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1 in Thailand. The Journal of Infectious Diseases. 196(11). 1629–1636. 32 indexed citations
18.
Arvold, Nils D., Nicole Ngo‐Giang‐Huong, Kenneth McIntosh, et al.. (2007). Maternal HIV-1 DNA Load and Mother-to-Child Transmission. AIDS Patient Care and STDs. 21(9). 638–643. 22 indexed citations
19.
Lallemant, Marc & Gonzague Jourdain. (1985). [The unacceptability of pregnancy among schoolgirls in Brazzaville].. PubMed. 21(2-3). 363–72. 1 indexed citations
20.
Lallemant, Marc & Gonzague Jourdain. (1985). La grossesse impossible chez les jeunes filles scolarisées à Brazzaville. 21. 363–372. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Willy Were Breakdown of academic impact, for papers by Isaac Zulu Breakdown of academic impact, for papers by Patrick Jean‐Philippe Breakdown of academic impact, for papers by Robert Downing Breakdown of academic impact, for papers by Dhayendre Moodley Breakdown of academic impact, for papers by Stewart E. Reid Breakdown of academic impact, for papers by Joseph Makhema Breakdown of academic impact, for papers by Shaffiq Essajee Breakdown of academic impact, for papers by Nagalingeswaran Kumarasamy Breakdown of academic impact, for papers by Mauro Schechter
Rankless by CCL
2026